Cost effectiveness of internet-based cognitive behaviour therapy and behavioural stress management for severe health anxiety

BMJ Open

Volumn 6, Issue 4, 2016, Pages

  Hedman, Erik ^a   Andersson, Erik ^a   Ljoeétsson, Brjaeénn ^a   Axelsson, Erland ^a   Lekander, Mats ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANXIETY; ARTICLE; BEHAVIORAL STRESS; COGNITIVE BEHAVIORAL THERAPY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DSM-IV; FEMALE; HEALTH CARE COST; HUMAN; HYPOCHONDRIASIS; INTERNET BASED COGNITIVE BEHAVIOUR THERAPY; INTERNET DELIVERED BEHAVIOURAL STRESS MANAGEMENT; INTERVENTION STUDY; INVESTIGATIVE PROCEDURES; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIMARY MEDICAL CARE; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL; SWEDEN; COST BENEFIT ANALYSIS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; ECONOMICS; INTERNET; MIDDLE AGED; PRIMARY HEALTH CARE; PROSPECTIVE STUDY; PSYCHOLOGICAL RATING SCALE; SELF REPORT; SEVERITY OF ILLNESS INDEX; SINGLE BLIND PROCEDURE; STATISTICS AND NUMERICAL DATA; THERAPY; TREATMENT OUTCOME;

ADULT; ANXIETY; COGNITIVE BEHAVIORAL THERAPY; COST-BENEFIT ANALYSIS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; INTERNET; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; QUALITY-ADJUSTED LIFE YEARS; SELF REPORT; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; SWEDEN; TREATMENT OUTCOME;

EID: 84971343298     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2015-009327     Document Type: Article

References (37)

1. Seivewright H, Salkovskis P, Green J, et al. Prevalence and service implications of health anxiety in genitourinary medicine clinics. Int J STD AIDS 2004;15:519-22.
2. Fink P, Ørnbol E, Christensen KS. The outcome of health anxiety in primary care. A two-year follow-up study on health care costs and self-rated health. PLoS ONE 2010;5:e9873.
3. Tyrer P, Cooper S, Crawford M, et al. Prevalence of health anxiety problems in medical clinics. J Psychosom Res 2011;71:392-4.
4. Barsky AJ, Fama JM, Bailey ED, et al. A Prospective 4- to 5-year study of DSM-III-R hypochondriasis. Arch Gen Psychiatry 1998;55:737-44.
5. Abramowitz JS, Braddock AE. Psychological treatment of health anxiety and hypochondriasis: A biopsychological approach. Cambridge, MA: Hogrefe & Huber Publishers, 2008.
6. Olatunji BO, Kauffman BY, Meltzer S, et al. Cognitive-behavioral therapy for hypochondriasis/health anxiety: A meta-analysis of treatment outcome and moderators. Behav Res Ther 2014;58:65-74.
7. King JT Jr, Tsevat J, Lave JR, et al. Willingness to pay for a quality-adjusted life year: implications for societal health care resource allocation. Med Decis Making 2005;25:667-77.
8. Seivewright H, Green J, Salkovskis P, et al. Cognitive-behavioural therapy for health anxiety in a genitourinary medicine clinic: randomised controlled trial. Br J Psychiatry 2008;193:332-7.
9. Tyrer P, Cooper S, Salkovskis P, et al. Clinical and cost-effectiveness of cognitive behaviour therapy for health anxiety in medical patients: A multicentre randomised controlled trial. Lancet 2014;383:219-25.
10. Hedman E, Andersson G, Andersson E, et al. Internet-based cognitive-behavioural therapy for severe health anxiety: randomised controlled trial. Br J Psychiatry 2011;198:230-6.
11. Hedman E, Axelsson E, Görling A, et al. Internet-delivered exposure-based cognitive-behavioural therapy and behavioural stress management for severe health anxiety: randomised controlled trial. Br J Psychiatry 2014;205:307-14.
12. Hedman E, Ljoeétsson B, Lindefors N. Cognitive behavior therapy via the internet: A systematic review of applications, clinical efficacy and cost-effectiveness. Expert Rev Pharmacoecon Outcomes Res 2012;12:745-64.
13. Hedman E, Andersson E, Lindefors N, et al. Cost-effectiveness and long-term effectiveness of internet-based cognitive behaviour therapy for severe health anxiety. Psychol Med 2013;43:363-74.
14. Mihalopoulos C, Chatterton ML. Economic evaluations of interventions designed to prevent mental disorders: A systematic review. Early Interv Psychiatry 2015;9:85-92.
15. Saha S, Hoerger TJ, Pignone MP, et al. The art and science of incorporating cost effectiveness into evidence-based recommendations for clinical preventive services. Am J Prev Med 2001;20:36-43.
16. Svanborg P, Åsberg M. A new self-rating scale for depression and anxiety states based on the Comprehensive Psychopathological Rating Scale. Acta Psychiatr Scand 1994;89:21-8.
17. McManus F, Surawy C, Muse K, et al. A randomized clinical trial of mindfulness-based cognitive therapy versus unrestricted services for health anxiety (hypochondriasis). J Consult Clin Psychol 2012;80:817-28.
18. Treanor M. The potential impact of mindfulness on exposure and extinction learning in anxiety disorders. Clin Psychol Rev 2011;31:617-25.
19. Hedman E, Ljoeétsson B, Andersson E, et al. Effectiveness and cost offset analysis of group CBT for hypochondriasis delivered in a psychiatric setting: An open trial. Cogn Behav Ther 2010;39:239-50.
20. Hedman E, Andersson E, Lindefors N, et al. Cost-effectiveness and long-term effectiveness of internet-based cognitive behaviour therapy for severe health anxiety. Psychol Med 2013;43:363-74.
21. Clark DM, Salkovskis PM, Hackmann A, et al. Two psychological treatments for hypochondriasis. A randomised controlled trial. Br J Psychiatry 1998;173:218-25.
22. Ost LG. Applied relaxation: description of a coping technique and review of controlled studies. Behav Res Ther 1987;25:397-409.
23. Ljoeétsson B, Hedman E, Andersson E, et al. Internet-delivered exposure-based treatment vs. stress management for irritable bowel syndrome: A randomized trial. Am J Gastroenterol 2011;106:1481-91.
24. Salkovskis PM, Rimes KA, Warwick HM, et al. The Health Anxiety Inventory: development and validation of scales for the measurement of health anxiety and hypochondriasis. Psychol Med 2002;32:843-53.
25. EuroQol-Group. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199-208.
26. Rabin R, De Charro F. EQ-SD: A measure of health status from the EuroQol Group. Ann Med 2001;33:337-43.
27. Hakkaart-van Roijen L, Donker MCH. Manual/iMTA questionnaire for costs associated with psychiatric illness (TIC-P). Institute of Medical Technology Assessment (iMTA) Erasmus University Rotterdam, 2002.
28. Drummond MF, Sculpher MJ, Torrence GW, et al. Methods for the evaluation of health care programmes. Oxford: Oxford University Press, 2005.
29. Hedman E, Ljoeétsson B, Rück C, et al. Internet administration of self-report measures commonly used in research on social anxiety disorder: A psychometric evaluation. Comput Hum Behav 2010;26:736-40.
30. Gueorguieva R, Krystal JH. Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry. Arch Gen Psychiatry 2004;61:310-17.
31. Jacobson NS, Truax P. Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol 1991;59:12-19.
32. Efron B, Tibshirani RJ. An introduction to the bootstrap. New York: Chapman & Hall, 1993.
33. Dolan P. Modeling valuations for EuroQol health states. Med Care 1997;35:1095-108.
34. Fenwick E, Byford S. A guide to cost-effectiveness acceptability curves. Br J Psychiatry 2005;187:106-8.
35. World Health Organization. WHO Commission on Macroeconomics and Health. Macroeconomics and Health: investing in health for economic development. Report of the Commission on Macroeconomics and Health Executive Summary. Geneva, 2001.
36. Statistics Sweden. Total income from employment and business 2013, 2015.
37. Patel A, Rendu A, Moran P, et al. A comparison of two methods of collecting economic data in primary care. Fam Pract 2005;22:323-7.